Skip to main content
. 2006 Dec;2(4):395–401.

Table 3.

Changes of surface markers in gossypol-treated HL-60 cells (in percentage)

CD11b CD13 CD14 CD33

HL-60 0.7 ± 0.2 7.9 ± 1.5 10.5 ± 1.2 99.0 ± 0.6
Treated HL-60 2.6 ± 0.1 56.5 ± 2.2a 31.4 ± 0.9a 99.7 ± 0.8
a

Value significantly different from those of control cells (P<0.01). The percentage of cell number in each cell phase is presented as mean ± S.D. (n=4).